SCHEMBL3341702

SCHEMBL3341702

NC1=CNC=NC1(N)C[C@H]1CCCO1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.33
MCL1 Q07820 1/20 0.33
HPGD P15428 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
PKM P14618 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
TSHR P16473 2/20 0.32
PDE8B O95263 2/20 0.31
CASP1 P29466 1/20 0.30
CASP7 P55210 1/20 0.30
HSD17B10 Q99714 1/20 0.30
POLB P06746 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3340212 1.00 ALDH1A1 (0.33) ALDH1A1MCL1HPGDTDP1MEN1
SCHEMBL3342926 1.00 ALDH1A1 (0.33) ALDH1A1MCL1HPGDTDP1MEN1
SCHEMBL3342929 0.72 ALDH1A1 (0.33) ALDH1A1MCL1HPGDTDP1MEN1
SCHEMBL3340214 0.72 ALDH1A1 (0.33) ALDH1A1MCL1HPGDTDP1MEN1
SCHEMBL3341705 0.72 ALDH1A1 (0.33) ALDH1A1MCL1HPGDTDP1MEN1
SCHEMBL6363797 0.70 TDP1 (0.32) ALDH1A1TDP1MEN1CYP1A2CYP3A4
SCHEMBL30515668 0.68 ALDH1A1 (0.37) ALDH1A1MCL1HPGDTDP1MEN1
SCHEMBL6239955 0.65 ALDH1A1 (0.34) ALDH1A1HPGDTDP1MEN1CYP1A2
SCHEMBL17437783 0.60 PKM (0.37) ALDH1A1HPGDMEN1PKMKMT2A
SCHEMBL16112324 0.58 TSHR (0.32) ALDH1A1HPGDMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252798-B2 Purine compounds ELI LILLY AND COMPANY (US) 2012-08-28 US disclosed
US-20100160288-A1 Purine Compounds ELI LILLY AND COMPANY 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160288-A1 Purine Compounds P2RX1, P2RX7, P2RX5 ALDH1A1 1108/4885MCL1 2615/4885HPGD 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.